Enhabit, Inc. (NYSE:EHAB) Given Consensus Rating of “Hold” by Analysts

Enhabit, Inc. (NYSE:EHAB) has received a consensus recommendation of “Hold” from the six brokerages that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $8.75.

Several analysts have recently issued reports on EHAB shares. Leerink Partners restated a “market perform” rating and issued a $8.00 price objective (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. Jefferies Financial Group raised shares of Enhabit from a “hold” rating to a “buy” rating and upped their price target for the stock from $8.25 to $9.50 in a research report on Monday, December 9th.

Enhabit Price Performance

Shares of NYSE EHAB opened at $7.60 on Wednesday. The firm has a market capitalization of $382.16 million, a P/E ratio of -3.28 and a beta of 1.82. Enhabit has a one year low of $6.85 and a one year high of $11.74. The company’s fifty day moving average is $7.82 and its two-hundred day moving average is $8.14. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46.

Enhabit (NYSE:EHAB) last posted its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same period last year, the company posted $0.03 EPS. Analysts forecast that Enhabit will post 0.22 EPS for the current fiscal year.

Insider Buying and Selling at Enhabit

In related news, Director Stuart M. Mcguigan purchased 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 10th. The shares were purchased at an average cost of $8.81 per share, with a total value of $132,150.00. Following the completion of the acquisition, the director now directly owns 46,810 shares of the company’s stock, valued at approximately $412,396.10. The trade was a 47.15 % increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jeffrey Bolton bought 4,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The stock was bought at an average price of $8.69 per share, for a total transaction of $34,760.00. Following the purchase, the director now owns 98,144 shares in the company, valued at approximately $852,871.36. This represents a 4.25 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in EHAB. FMR LLC increased its stake in shares of Enhabit by 138.4% in the third quarter. FMR LLC now owns 3,388 shares of the company’s stock valued at $27,000 after purchasing an additional 1,967 shares during the period. Quarry LP raised its stake in Enhabit by 242.2% during the 2nd quarter. Quarry LP now owns 3,703 shares of the company’s stock valued at $33,000 after purchasing an additional 2,621 shares during the period. Gladius Capital Management LP raised its position in Enhabit by 78.2% during the third quarter. Gladius Capital Management LP now owns 6,259 shares of the company’s stock valued at $49,000 after buying an additional 2,747 shares during the period. Franklin Resources Inc. lifted its position in shares of Enhabit by 19.6% in the third quarter. Franklin Resources Inc. now owns 32,382 shares of the company’s stock worth $256,000 after purchasing an additional 5,317 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its position in Enhabit by 1.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 400,575 shares of the company’s stock worth $3,573,000 after buying an additional 5,936 shares in the last quarter.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.